Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The vitamin E-bonded polysulfone membrane hemodialyzer (ViE™-21) was evaluated in a clinical study for regulatory submission. Seventeen patients on hemodialysis were treated with conventional high-flux hemodialyzers for 2 weeks (Pre-ViE phase) and switched to the ViE-21 for 36 sessions (ViE phase) followed by an additional 2 weeks on conventional hemodialyzers (Post-ViE phase). Reduction ratios of urea, creatinine, beta-2-microglobulin, albumin, and ultrafiltration coefficients (KUF) were measured once during the Pre-ViE phase and twice during the ViE phase. Moreover, biocompatibility markers [leucocyte count, platelet count, and activated complement factor (C3a) levels] were evaluated pre-dialysis, 15 min after initiation, and post-dialysis. During the study, type and number of adverse events (AEs), and device malfunctions were recorded. ViE-21 reduction ratios and KUF were not noticeably different than those of conventional hemodialyzers. Fluctuations of leucocyte counts and C3a concentrations were similar using ViE-21 and conventional hemodialyzers; however, the platelet count fluctuation was lower in ViE-21 sessions. The frequency of episodes of hypotension occurring during the ViE phase was lower than that occurring during the Pre- and Post-ViE phases. In conclusion, this study provided performance and safety data of the ViE-21 for regulatory application. The data suggest that vitamin E-bonded hemodialyzers are beneficial in lowering platelet activation and frequency of intradialytic hypotension. Larger randomized controlled trials are needed to confirm these findings.
Bowry SK. Nano-controlled membrane spinning technology: regulation of pore size, distribution and morphology of a new polysulfone dialysis membrane. Contrib Nephrol. 2002;137:85–94. CrossRef
Krane V, Krieter DH, Olschewski M, et al. Dialyzer membrane characteristics and outcome of patients with type 2 diabetes on maintenance hemodialysis. Am J Kidney Dis. 2007;49:267–75. CrossRef
Del Vecchio L, Locatelli F, Carini M. What we know about oxidative stress in patients with chronic kidney disease on dialysis-clinical effects, potential treatment, and prevention. Semin Dial. 2011;24:56–64. CrossRef
Galli F. Vitamin E-modified dialyzers. Contrib Nephrol. 2002;137:95–105. CrossRef
Floridi A, Piroddi M, Pilolli F, Matsumoto Y, Aritomi M, Galli F. Analysis method and characterization of the antioxidant capacity of vitamin E-interactive polysulfone hemodialyzers. Acta Biomater. 2009;5:2974–82. CrossRef
Aritomi M, Galli F. Review of the effectiveness of cellulose- and polysulfone-based vitamin E-bonded dialysis membranes. In: Technical problems in patients on hemodialysis (Intech open access book), 2011; 17, 295–302.
Piroddi M, Pilolli F, Aritomi M, Galli F. Vitamin E as a functional and biocompatibility modifier of synthetic hemodialyzer membranes: an overview of the literature on vitamin E-modified hemodialyzer membranes. Am J Nephrol. 2012;35:559–72. CrossRef
Yamadera S, Nakamura Y, Inagaki M, et al. Vitamin E-coated dialyzer inhibits oxidative stress. Blood Purif. 2017;44:288–93. CrossRef
FDA Guidance for Industry and CDRH Reviewers (1998) Guidance for the content of premarket notifications for conventional and high permeability hemodialyzers
ISO 14155 (2011) Clinical investigation of medical devices for human subjects—good clinical practice, Second edition
Aoun B, Janssen-Lozinska Y, Ulinski T. Effect of vitamin E coated dialyzers on anticoagulation requirement in hemodialyzed children. Saudi J Kidney Dis Transpl. 2010;21:466–70.
Torato T, Doi K, Negishi K, et al. Efficacy of vitamin E-bonded polysulfone dialyzer and polysulfone dialyzer on a series of non-anticoagulant hemodialysis. ASAIO J. 2013;59:284–5. CrossRef
Islam MS, Hassan ZA, Chalmin F, et al. Vitamin E-coated and heparin-coated dialyzer membranes for heparin-free hemodialysis: A multicenter, randomized, crossover trial. Am J Kidney Dis. 2016;68:752–62. CrossRef
Tsukao H, Kokubo K, Takahashi H, et al. Activation of platelets upon contact with a vitamin E-coated/non-coated surface. J Artif Organs. 2013;16:193–205. CrossRef
Matsumura M, Sasaki H, Sekizuka K, et al. Improved management of intradialytic hypotension (IDH) using vitamin E-bonded polysulfone membrane dialyzer. Int J Artif Organs. 2010;33:147–53. CrossRef
Koremoto M, Takahara N, Takahashi M, et al. Improvement of intradialytic hypotension in diabetic hemodialysis patients using vitamin E-bonded polysulfone membrane dialyzers. Artif Organs. 2012;36:901–10. CrossRef
Andrulli S, Di Filippo S, Manzoni C, et al. Effect of synthetic vitamin E-bonded membrane on responsiveness to erythropoiesis-stimulating agents in hemodialysis patients: a pilot study. Nephron Clin Pract. 2010;115:c82–9. CrossRef
Panichi V, Rosati A, Paoletti S, et al. A vitamin E-coated polysulfone membrane reduces serum levels of inflammatory markers and resistance to erythropoietin-stimulating agents in hemodialysis patients: results of a randomized cross-over multicenter trial. Blood Purif. 2011;32:7–14. CrossRef
Mandolfo S, Corradi B, Bucci R, Farina M, Pilolli F, Galli F. Evaluation of the impact of a new synthetic vitamin E-bonded membrane on anemia and rHuEPO requirement in ESRD patients with central venous catheters: a pilot study. Int Urol Nephrol. 2012;44:1493–500. CrossRef
Lines SW, Carter AM, Dunn EJ, Lindley EJ, Tattersall JE, Wright MJ. A randomized controlled trial evaluating the erythropoiesis stimulating agent sparing potential of a vitamin E-bonded polysulfone dialysis membrane. Nephrol Dial Transplant. 2014;29:649–56. CrossRef
Sanaka T, Mochizuki T, Kinugasa E, et al. Randomized controlled open-label trial of vitamin E-bonded polysulfone dialyzer and erythropoiesis-stimulating agent response. Clin J Am Soc Nephrol. 2013;8:969–78. CrossRef
Bargnoux AS, Cristol JP, Jaussent I, et al. Vitamin E-coated polysulfone membrane improved red blood cell antioxidant status in hemodialysis patients. J Nephrol. 2013;26:556–63. CrossRef
Locatelli F, Andrulli S, Viganò SM, et al. Evaluation of the impact of a new synthetic vitamin E-bonded membrane on the hypo-responsiveness to the erythropoietin therapy in hemodialysis patients: a multicenter study. Blood Purif. 2017;43:338–45. CrossRef
D'Arrigo G, Baggetta R, Tripepi G, Galli F, Bolignano D. Effects of vitamin E-coated versus conventional membranes in chronic hemodialysis patients: a systematic review and meta-analysis. Blood Purif. 2016;43:101–22. CrossRef
Morimoto H, Nakao K, Fukuoka K, et al. Long-term use of vitamin E-coated polysulfone membrane reduces oxidative stress markers in hemodialysis patients. Nephrol Dial Transplant. 2005;20:2775–82. CrossRef
Calò LA, Naso A, D'Angelo A, et al. Molecular biology-based assessment of vitamin E-coated dialyzer effects on oxidative stress, inflammation, and vascular remodeling. Artif Organs. 2011;35:E33–E39.
Kitamura Y, Kamimura K, Yoshioka N, et al. The effect of vitamin E-bonded polysulfone membrane dialyzer on a new oxidative lipid marker. J Artif Organs. 2013;16:206–10. CrossRef
- Clinical evaluation of performance, biocompatibility, and safety of vitamin E-bonded polysulfone membrane hemodialyzer compared to non-vitamin E-bonded hemodialyzer
- Springer Japan
Journal of Artificial Organs
The Official Journal of the Japanese Society for Artificial Organs
Print ISSN: 1434-7229
Elektronische ISSN: 1619-0904
Neu im Fachgebiet Chirurgie
Mail Icon II